Accendra Health Total Debt Growth & History (ACH)
Accendra Health's total debt was $1.91B for fiscal 2025.
View full Accendra Health company overviewAccendra Health annual total debt history
| Fiscal year | Period ended | Total debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.91B | −$15.6M | −0.81% |
| 2024 | 2024-12-31 | $1.93B | −$269.6M | −12.26% |
| 2023 | 2023-12-31 | $2.20B | −$576.5M | −20.77% |
| 2022 | 2022-12-31 | $2.78B | $1.62B | +140.99% |
| 2021 | 2021-12-31 | $1.15B | −$38.9M | −3.27% |
| 2020 | 2020-12-31 | $1.19B | −$530.5M | −30.82% |
| 2019 | 2019-12-31 | $1.72B | $25.6M | +1.51% |
| 2018 | 2018-12-31 | $1.70B | $757.1M | +80.70% |
| 2017 | 2017-12-31 | $938.3M | $344.3M | +57.97% |
| 2016 | 2016-12-31 | $593.9M | −$9.1M | −1.51% |
| 2015 | 2015-12-31 | $603.1M | −$43.1M | −6.67% |
| 2014 | 2014-12-31 | $646.2M | $417.7M | +182.83% |
| 2013 | 2013-12-31 | $228.5M | −$970,000 | −0.42% |
| 2012 | 2012-12-31 | $229.4M | $7.8M | +3.52% |
| 2011 | 2011-12-31 | $221.6M | $4.6M | +2.14% |
| 2010 | 2010-12-31 | $217.0M | $8.6M | +4.12% |
| 2009 | 2009-12-31 | $208.4M | — | — |
Accendra Health quarterly total debt
| Fiscal quarter | Period ended | Total debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.82B | $100.3M | +5.83% |
| Q1 2026 | 2026-03-31 | $1.59B | −$632.1M | −28.45% |
| Q4 2025 | 2025-12-31 | $1.91B | −$15.6M | −0.81% |
| Q3 2025 | 2025-09-30 | $1.96B | −$167.7M | −7.87% |
| Q2 2025 | 2025-06-30 | $1.72B | −$450.1M | −20.75% |
| Q1 2025 | 2025-03-31 | $2.22B | −$785,000 | −0.04% |
| Q4 2024 | 2024-12-31 | $1.93B | −$269.6M | −12.26% |
| Q3 2024 | 2024-09-30 | $2.13B | −$293.6M | −12.11% |
| Q2 2024 | 2024-06-30 | $2.17B | −$441.7M | −16.91% |
| Q1 2024 | 2024-03-31 | $2.22B | −$348.4M | −13.55% |
| Q4 2023 | 2023-12-31 | $2.20B | −$576.5M | −20.77% |
| Q3 2023 | 2023-09-30 | $2.42B | −$411.1M | −14.50% |
| Q2 2023 | 2023-06-30 | $2.61B | −$244.6M | −8.56% |
| Q1 2023 | 2023-03-31 | $2.57B | −$353.6M | −12.09% |
| Q4 2022 | 2022-12-31 | $2.78B | $1.62B | +140.99% |
| Q3 2022 | 2022-09-30 | $2.84B | $1.72B | +154.61% |
| Q2 2022 | 2022-06-30 | $2.86B | $1.70B | +147.04% |
| Q1 2022 | 2022-03-31 | $2.92B | $1.81B | +163.00% |
| Q4 2021 | 2021-12-31 | $1.15B | −$38.9M | −3.27% |
| Q3 2021 | 2021-09-30 | $1.11B | −$106.2M | −8.71% |
| Q2 2021 | 2021-06-30 | $1.16B | −$231.7M | −16.70% |
| Q1 2021 | 2021-03-31 | $1.11B | −$481.8M | −30.23% |
| Q4 2020 | 2020-12-31 | $1.19B | −$530.5M | −30.82% |
| Q3 2020 | 2020-09-30 | $1.22B | −$574.4M | −32.02% |
| Q2 2020 | 2020-06-30 | $1.39B | −$447.7M | −24.39% |
| Q1 2020 | 2020-03-31 | $1.59B | −$292.0M | −15.48% |
| Q4 2019 | 2019-12-31 | $1.72B | $25.6M | +1.51% |
| Q3 2019 | 2019-09-30 | $1.79B | $153.6M | +9.36% |
| Q2 2019 | 2019-06-30 | $1.84B | $165.9M | +9.94% |
| Q1 2019 | 2019-03-31 | $1.89B | $988.6M | +110.21% |
| Q4 2018 | 2018-12-31 | $1.70B | $757.1M | +80.70% |
| Q3 2018 | 2018-09-30 | $1.64B | $723.2M | +78.84% |
| Q2 2018 | 2018-06-30 | $1.67B | $1.09B | +188.28% |
| Q1 2018 | 2018-03-31 | $897.1M | $332.9M | +59.01% |
| Q4 2017 | 2017-12-31 | $938.3M | $344.3M | +57.97% |
| Q3 2017 | 2017-09-30 | $917.3M | $350.8M | +61.92% |
| Q2 2017 | 2017-06-30 | $579.1M | $12.2M | +2.15% |
| Q1 2017 | 2017-03-31 | $564.1M | −$3.6M | −0.63% |
| Q4 2016 | 2016-12-31 | $593.9M | −$9.1M | −1.51% |
| Q3 2016 | 2016-09-30 | $566.5M | −$7.6M | −1.32% |
| Q2 2016 | 2016-06-30 | $567.0M | −$7.7M | −1.33% |
| Q1 2016 | 2016-03-31 | $567.7M | −$6.9M | −1.20% |
| Q4 2015 | 2015-12-31 | $603.1M | −$43.1M | −6.67% |
| Q3 2015 | 2015-09-30 | $574.0M | $10.2M | +1.80% |
| Q2 2015 | 2015-06-30 | $574.6M | $355.5M | +162.27% |
| Q1 2015 | 2015-03-31 | $574.6M | $359.8M | +167.48% |
| Q4 2014 | 2014-12-31 | $646.2M | $417.7M | +182.83% |
| Q3 2014 | 2014-09-30 | $563.9M | $349.5M | +162.99% |
| Q2 2014 | 2014-06-30 | $219.1M | $4.4M | +2.06% |
| Q1 2014 | 2014-03-31 | $214.8M | $583,000 | +0.27% |
| Q4 2013 | 2013-12-31 | $228.5M | −$970,000 | −0.42% |
| Q3 2013 | 2013-09-30 | $214.4M | −$379,000 | −0.18% |
| Q2 2013 | 2013-06-30 | $214.7M | $2.6M | +1.25% |
| Q1 2013 | 2013-03-31 | $214.2M | $2.0M | +0.92% |
| Q4 2012 | 2012-12-31 | $229.4M | $7.8M | +3.52% |
| Q3 2012 | 2012-09-30 | $214.8M | $1.7M | +0.79% |
| Q2 2012 | 2012-06-30 | $212.0M | −$105,000 | −0.05% |
| Q1 2012 | 2012-03-31 | $212.3M | $3.3M | +1.57% |
| Q4 2011 | 2011-12-31 | $221.6M | $4.6M | +2.14% |
| Q3 2011 | 2011-09-30 | $213.1M | $4.5M | +2.17% |
| Q2 2011 | 2011-06-30 | $212.1M | $4.2M | +2.04% |
| Q1 2011 | 2011-03-31 | $209.0M | — | — |
| Q4 2010 | 2010-12-31 | $217.0M | $8.6M | +4.12% |
| Q3 2010 | 2010-09-30 | $208.6M | — | — |
| Q2 2010 | 2010-06-30 | $207.9M | — | — |
| Q4 2009 | 2009-12-31 | $208.4M | — | — |
Accendra Health total debt trends
Over the last five fiscal years, Accendra Health's total debt increased from $1.19B to $1.91B, a change of $722.9M. The latest reported quarter, Q2 2026, shows $1.82B.
What total debt means
Total debt measures a company’s reported interest-bearing borrowing obligations at a reporting-period end. It can include short-term borrowings, current maturities, long-term debt, and finance lease obligations when they are included in the company’s debt facts.
SEC-reported and combined total debt
TickerStat uses a reported aggregate debt value when available. Otherwise, it combines non-overlapping current and noncurrent debt facts from SEC filings. Total liabilities are not treated as debt, and missing debt is not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Accendra Health source filings ↗